Literature DB >> 14751050

[Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry].

Hong-qiang Shen1, Yong-min Tang, Shi-long Yang, Bo-qin Qian, Hua Song, Shu-wen Shi, Wei-qun Xu.   

Abstract

OBJECTIVE: Acute leukemia (AL) is one of the most common malignant diseases in children. AL immunophenotypes are known to be benefit to the predictable prognoses and specific therapy. Recently, the accuracy of AL immunophenotyping was dramatically improved with the application of the flow cytometry, the new monoclonal antibodies, the improvement of the gating strategies and the multi-parameter analytic techniques. The aim of this study was to evaluate the value of multi-color flow cytometry in the immunophenotyping of acute leukemia in children.
METHODS: Three- or four-color flow cytometry and CD(45)/Side Scatter (SSC) gating were used to analyze the surface and cytoplasmic (Cy) antigen expressions in 222 successive cases of childhood acute leukemia.
RESULTS: Cells from 222 cases of children with acute leukemia were analyzed. Based on the diagnostic criterion proposed by European Group for the Immunological Characterization of Leukemia (EGIL), four categories could be identified: the undifferentiated type accounted for 0.9%, acute myeloid leukemia (AML) 35.1%, acute lymphoblastic leukemia (ALL) 55.9%, and mixed lineage AL 8.1%. Of 124 patients with ALL, 94 patients (75.8%) were classified as B lineage and 30 patients (24.2%) T lineage ALL. Antigen aberrant expressions were found in AML (24.4%), B lineage ALL (36.2%) and T lineage ALL (30.0%). CD(7) was the most commonly expressed lymphoid antigen in AML (12.8%), followed by CD(19) (6.4%) and CD(2) (5.1%). CD(13) was the most commonly expressed myeloid antigen in ALL (18.5%), followed by CD(15) (11.3%), CD(11b) (6.5%) and CD(33) (4.3%). CD(117) and CD(56) presented in 73.3% and 38.0% cases of AML, respectively, but were generally absent on blast cells of ALL. CyCD(22), CyCD(3) and CyMPO were specifically expressed in B lineage, T lineage and myeloid lineage leukemia, respectively, and the first two could be more sensitively detected than they were on cell membrane surface.
CONCLUSIONS: Multi-color flow cytometry is a reliable technique in the diagnosis, differential diagnosis and classification of acute leukemia in children.

Entities:  

Mesh:

Year:  2003        PMID: 14751050

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN: 0578-1310


  5 in total

1.  Aberrant phenotype in Iranian patients with acute myeloid leukemia.

Authors:  Mehdi Jahedi; Karim Shamsasenjan; Zohreh Sanaat; Mohammadreza Aliparasti; Shohreh Almasi; Mozhdeh Mohamadian; Babak Nejati; Amir Kamalifar; Ali Akbar Movassaghpour
Journal:  Adv Pharm Bull       Date:  2013-12-23

2.  Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome.

Authors:  Bharat Bhushan; Pradeep Singh Chauhan; Sumita Saluja; Saurabh Verma; Ashwani Kumar Mishra; Saeed Siddiqui; Sujala Kapur
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

3.  Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience.

Authors:  Dalia A Salem; Sherin M Abd El-Aziz
Journal:  Indian J Hematol Blood Transfus       Date:  2011-09-21       Impact factor: 0.900

4.  Aberrant myeloid antigen co-expression is correlated with high percentages of CD34-positive cells among blasts of acute lymphoblastic leukemia patients: an Indian tertiary care center perspective.

Authors:  Rahul Kumar Sharma; Abhishek Purohit; Venkatesan Somasundaram; Pravas Chandra Mishra; Mrinalini Kotru; Ravi Ranjan; Sunil Kumar; Sudha Sazawal; Hara Prasad Pati; Seema Tyagi; Renu Saxena
Journal:  Blood Res       Date:  2014-12-23

5.  Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience.

Authors:  Nishit Gupta; Ravikiran Pawar; Sambhunath Banerjee; Subhajit Brahma; Asish Rath; Sundar Shewale; Mayur Parihar; Manish Singh; S R Arun; Shekhar Krishnan; Arpita Bhatacharyya; Anirban Das; Jeevan Kumar; Saurabh Bhave; Vivek Radhakrishnan; Reena Nair; Mammen Chandy; Neeraj Arora; Deepak Mishra
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-03-01       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.